Current Opinion in Oncology

Article	Citations
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	67
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	45
Role of PSMA PET/CT in imaging and management of prostate cancer	39
Editorial introductions	37
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	36
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma	31
Treatments and challenges in advanced prostate cancer	31
Optimal management of oligometastatic prostate cancer: current state and future directions	29
Psycho-oncology interventions focusing on fatigue and sleep disturbances	28
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	26
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	26
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	23
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	22
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	20
Cancer survivors living with chronic pain: patient and healthcare professional perspectives and current recommendations	20
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	20
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	19
Editorial introductions	17
Safety of assisted reproductive techniques in gynecological cancer patients	16
Editorial introductions	16
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	15
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	14
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	14
Editorial introductions	13
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	13

How to prevent human papillomavirus-related oropharyngeal cancer?	13
Biomarkers and immunotherapy: where are we?	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	13
Indications and technique of minimally invasive surgery in early-stage cervical cancer	13
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	13
Open questions on vorasidenib	13
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	12
Editorial introductions	12
New hopes in relapsed refractory primary central nervous system lymphoma	12
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	12
The evolving landscape of bispecific antibodies in the treatment of lung cancer	12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12
Circulating tumor DNA in breast cancer: a biomarker for patient selection	12
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	11
Liquid biopsy in brain tumors: moving on, slowly	11
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	11
Recent highlights and breakthroughs in immunotherapy for head and neck cancers	11
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	11
Recent advances in precision medicine for acute myeloid leukemia	11
Pathology and new insights in central nervous system lymphomas	10
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	10
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	10
Lung cancer screening in never smokers	10
Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings	10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	10
Artificial intelligence in lung cancer: from diagnosis to therapy	10
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	9
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	9
Machine learning applications and challenges in graft-versus-host disease: a scoping review	9
Melanoma in adolescents and young adults: special considerations	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Current role and indications of minimally invasive surgery in gynecologic oncology	8
Mind the target: programmed death ligand 1 in oesophagogastric cancers	8
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	8
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	8
Editorial introductions	8
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	8
Advantages of robotic surgery in obese patients with endometrial cancer	8
A new comprehensive and stratified concept for supportive care in cancer patients	8
Desmoid tumors: who, when and how to treat?	8
Editorial introductions	8
Editorial introductions	7
Potential application of artificial intelligence in cancer therapy	7
Targeting cancer stem cell pathways for lung cancer therapy	7
Adjuvant and neoadjuvant approaches in pancreatic cancer	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7

Treatment of radiation-associated angiosarcoma	7
Editorial introductions	7
How to support parenting in patients with cancer and co-parents? From research to practice	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Evolving paradigms in the management of basal cell carcinoma	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
Question prompt lists to improve communication between cancer patients and healthcare professionals	7
Breast surgery after neoadjuvant therapy	7
Global priorities for advancing cancer survivorship	7
New therapies for brain metastases: an update	7
Application of single-port techniques in endometrial cancer	7
Pathologic diagnosis of lung cancer – recent developments	7
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer	7
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	7
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
HIV-related lymphomas	6
Clinical management of brain tumors in pregnancy	6
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	6
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	6
Cellular therapies in sarcoma and other solid tumors	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	6
Richter transformation: biological insights, diagnostic challenges and emerging therapies	6
How to monitor the side effects of treatments in cancer patients	6
Polyamine metabolism in prostate cancer	6
Precision, personalization, and quality of life for patients with lymphoma	6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
How to treat localized Hodgkin lymphoma?	6
Unclear territory: navigating metastatic nonclear cell renal cell carcinoma	6
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	6
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	6
Patient-proxy agreement on health-related quality of life assessment in cancer patients	6
Achievements of international rare cancers networks and consortia in the neuro-oncology field	6
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	5
Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions	5
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
High-risk smoldering myeloma – a case for early intervention?	5
Targeting exon 20 insertion mutations in lung cancer	5
Update of antibody–drug conjugates for hematological malignancies	5
Editorial introductions	5
Immunotherapy of sarcomas with modified T cells	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	5
Molecular genotyping in medullary thyroid cancer	5
Recent advances in immunotherapy for small cell lung cancer	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	4
Targeting androgen receptors in patients with metastatic breast cancer	4
Treatment of lung cancer in pregnant women	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
How to treat advanced Hodgkin lymphoma?	4
Editorial introductions	4
Future of sentinel node biopsy in ovarian cancer	4
New strategies for the treatment of breast cancer with leptomeningeal metastasis	4
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	4
Supportive care in the world: an international opinion on MASCC's perspectives	4
New trends in supportive care of head and neck cancers	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Vascular complications in patients with brain tumors	4
Epithelioid sarcoma: from SMARCB1 loss to therapeutic vulnerabilities	4
Editorial: Psychological interventions in oncology: advances and challenges	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Early Detection of Cancers in the Era of Precision Oncology	4
Editorial: Advanced care planning	3
CIC-DUX4 sarcomas	3
Editorial Introductions	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Sarculator: how to improve further prognostication of all sarcomas	3
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists	3
Circulating tumor DNA for human papilloma virus-positive disease: ready for prime time?	3
Emerging therapies in Ewing sarcoma	3

New treatment strategies for primary central nervous system lymphoma	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
New treatments for desmoid tumors	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Editorial introductions	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Advances in the treatment of light chain amyloidosis	3
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	3
Circulating tumor DNA in B cell lymphomas	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
Editorial introductions	3
Cancer-associated thrombosis: what is new?	3
New targeted treatments for advanced sarcomas	3
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Action against thoracic cancers: recent achievements and perspectives	3
Reframing distress in oncology: the potential of psychedelic-assisted therapy	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	3
Evolving systemic management of urothelial cancers	3
First line treatments in primary central nervous system lymphomas in young patients	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Management of epilepsy in brain tumor patients	3
The role of next-generation sequencing in acute myeloid leukemia	3
Use of staging for sex cord stromal tumours	3
Advance care planning in oncology: a scoping review and some recommendations	3
Challenges in the management of relapsed germ cell tumors	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Medical treatment of angiosarcomas	2
Novel therapeutics in refractory germ cell tumors	2
Prophylactic cranial irradiation in small cell lung cancer: an update	2
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	2
Stereotactic ablative radiation therapy in metastatic prostate cancer	2
Beyond the usual – Atypical imaging presentation in lung cancer and implications for TNM-staging	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Chimeric antigen receptor T-cell therapy for multiple myeloma	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Biomarkers in advanced renal cell carcinoma: current practice and future directions	2
Mantle cell lymphoma: how to clarify the confusion around first-line treatment?	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Circulating tumor DNA in early-stage triple-negative breast cancer: clinical landscape and key open challenges	2
The role of menin inhibitors in acute myeloid leukemia	2
New targeted therapies in liposarcoma: state of art and future perspectives	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
Interventions for children of parents with cancer: an overview	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
Editorial introductions	2
Immuno-oncology in the daily practice	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
Treatment approaches for older Hodgkin lymphoma patients	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Prognostic factors in primary central nervous system lymphoma	2
Liquid biopsy in breast cancer: promises and challenges	2
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	2
Reirradiation in recurrent glioblastoma	2
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decades	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
Recent developments and outstanding challenges in germ cell tumors	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2